Combining Diffusion-Weighted Imaging and T2-Weighted Imaging to Delineate Tumorous Tissue in Peritoneal Carcinomatosis: A Comparative Study with 18F-Fluoro-Deoxyglucose Positron Emission Tomography with Computed Tomography (FDG PET/CT)

Qing Wu; Xiufang Xu

doi:10.12659/MSM.934664

04 April 2022: Clinical Research

Combining Diffusion-Weighted Imaging and T2-Weighted Imaging to Delineate Tumorous Tissue in Peritoneal Carcinomatosis: A Comparative Study with 18F-Fluoro-Deoxyglucose Positron Emission Tomography with Computed Tomography (FDG PET/CT)

Qing Wu ^ABC , Xiufang Xu ^DEF*

DOI: 10.12659/MSM.934664

Med Sci Monit 2022; 28:e934664

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Figure 2 Scatterplot of volume estimates using magnetic resonance imagining vs that using positron emission tomography with computed tomography; corresponding linear regression fit lines were also added.

Back to the Article

Combining Diffusion-Weighted Imaging and T2-Weighted Imaging to Delineate Tumorous Tissue in Peritoneal Carcinomatosis: A Comparative Study with 18F-Fluoro-Deoxyglucose Positron Emission Tomography with Computed Tomography (FDG PET/CT)

Your Privacy